Proteins and Peptides

09 Jun 2008 Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
09 Jun 2008 New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
08 Jun 2008 Clinical study shows liraglutide provides statistically significantly better blood glucose control than exenatide
05 Jun 2008 Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
05 Jun 2008 BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome
05 Jun 2008 Generex Biotechnology Commences Patient Dosing For Pivotal Phase III Trial of Generex Oral-lyn
05 Jun 2008 Pacgen Announces Positive Results from Phase IIb Dose-Ranging Trial of PAC-113
05 Jun 2008 SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
04 Jun 2008 Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p
04 Jun 2008 The GI Company Reports Significant Reduction In Occurrence Of Oral Mucositis In Phase II Study Presented At ASCO
04 Jun 2008 Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
03 Jun 2008 Mentor Announces Completion of Enrollment in Phase I Trial for Botulinum Toxin Type A in Patients with Cervical Dystonia
02 Jun 2008 Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128 (long-acting factor VIIa) (2 Jun 2008)
02 Jun 2008 Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
30 May 2008 TransMolecular Initiates Phase 1 Clinical Trial for Unlabeled TM601 in Recurrent Malignant Glioma
30 May 2008 Boehringer Ingelheim gets first approval within EU for Actilyse(R) 2mg to treat catheter dysfunction caused by thrombotic occlusion
29 May 2008 Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
28 May 2008 Stem Cell Therapeutics Corp. Announces Enrollment of the First Patient in its REGENESIS Phase IIb Stroke Trial
27 May 2008 ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
27 May 2008 Biovitrum and Syntonix Dose First Hemophilia B Patient in Clinical Trial of a Novel Factor IXFc Treatment
26 May 2008 Extavia(R) approved in European Union for treatment of multiple sclerosis, first in planned portfolio of therapies from Novartis
23 May 2008 Novo Nordisk files for regulatory approval of liraglutide in both the US and Europe
23 May 2008 Allon completes dosing in Phase II cognitive impairment trial
23 May 2008 ThromboGenics Presents Further Results of the Vitreomacular Traction Trial (MIVI IIT) at the Euretina Annual Meeting in Vienna
21 May 2008 Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) for Chronic Obstructive Pulmonary Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up